trecondi
medac gesellschaft für klinische spezialpräparate mbh - treosulfan - hematopoetična presaditev izvornih celic - antineoplastična sredstva - treosulfan in combination with fludarabine is indicated as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (allohsct) in adult patients and in paediatric patients older than one month with malignant and non-malignant diseases.
amversio
serb sa - betaine - homocistinurija - drugi zdravljene bolezni prebavil in presnove izdelki, - amversio is indicated as adjunctive treatment of homocystinuria, involving deficiencies or defects in:• cystathionine beta-synthase (cbs),• 5,10 methylene tetrahydrofolate reductase (mthfr),• cobalamin cofactor metabolism (cbl).
androcur 100 mg tablete
bayer d.o.o. - ciproteronacetat - tableta - ciproteronacetat 100 mg / 1 tableta - ciproteron
androcur 50 mg tablete
bayer d.o.o. - ciproteronacetat - tableta - ciproteronacetat 50 mg / 1 tableta - ciproteron
leptoprol 5 mg implantat v napolnjeni injekcijski brizgi
sandoz d.d. - levprorelin - implantat - levprorelin 5 mg / 1 brizga - levprorelin
kalcij/vitamin d3 lek 1000 mg/880 i.e. žvečljive tablete
lek d.d. - holekalciferol (vitamin d3); kalcij - žvečljiva tableta - holekalciferol (vitamin d3) 880 mg / 1 tableta kalcij1000 mg / 1 tableta; kalcij 1000 mg / 1 tableta - kalcij, kombinacije z vitaminom d in/ali drugimi učinkovinami
omnipaque 240 mg i/ml raztopina za injiciranje
ge healthcare as - jod - raztopina za injiciranje - jod 240 mg / 1 mljoheksol - joheksol
omnipaque 300 mg i/ml raztopina za injiciranje
ge healthcare as - jod - raztopina za injiciranje - jod 300 mg / 1 ml - joheksol
omnipaque 350 mg i/ml raztopina za injiciranje
ge healthcare as - jod - raztopina za injiciranje - jod 350 mg / 1 mljoheksol - joheksol
omnipaque 350 mg i/ml raztopina za injiciranje
ge healthcare as - jod - raztopina za injiciranje - jod 350 mg / 1 ml - joheksol